Important Findings to Be Presented by Mount Sinai Researchers at the 2014 American Urological Association Meeting
Data on an immune response in prostate cancer tumors, effects of paternal age on stimulated insemination live birth rates, issues of sexual function after cystectomy and a comparison of modalities for the treatment of benign prostatic hyperplasia (BPH) were amongst the studies that were presented by researchers at the Icahn School of Medicine at Mount Sinai at the 2014 American Urological Association (AUA) annual meeting May 17 – 19 in Orlando. Meeting attendees were able to view a live 3-dimensional video feed of a robotic prostatectomy performed by Ashutosh K. Tewari, MB, BS, Chairman of the Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai. "Study data demonstrated that a subset of patients (30 percent) vaccinated against one specific antigen, PAP, develop immune response to other antigens; this antigen spread is associated with a profound enhancement of survival. This study thus demonstrates some of the complexities of immunotherapy in patients and serves as a backdrop for further studies to enhance anticancer immune therapies," said Simon Hall, MD, Director of the Barbara and Maurice Deane Prostate Health and Research Center, and Associate Professor of Urology at the Icahn School of Medicine at Mount Sinai. In addition, a research team at Icahn School of Medicine at Mount Sinai, led by Natan Bar-Chama, MD, Associate Professor of Urology and Obstetrics, Gynecology and Reproductive Science at the Icahn School of Medicine at Mount Sinai sought to answer whether paternal age had a negative impact on the ability to reproduce and the rate of successful outcomes using stimulated intrauterine insemination (IUI). "This study the largest of its kind to date, clearly demonstrates that advanced paternal age negatively impacts fertility outcomes in couples undergoing the most common form of assisted reproductive technologies; stimulated intrauterine inseminations," said Dr. Bar-Chama. Also at the meeting was Nihal Mohamed, PhD, Assistant Professor of Urology at the Icahn School of Medicine at Mount Sinai, whose research will provide vital insight to the patient's full spectrum of needs and information that will guide further enhancements of supportive care resources available for bladder cancer patients and survivors. "Understanding the needs of our patients is pivotal to improving health outcomes and achieving patients' and families' satisfaction," said Dr. Mohamed.
-Dr. Ashutosh K. Tewari, Chairman, Milton and Carroll Petrie Department of Urology, Icahn School of Medicine at Mount Sinai
-Dr. Simon Hall, Director, Barbara and Maurice Deane Prostate Health Center, Associate Professor, Urology, Icahn School of Medicine at Mount Sinai
-Dr. Natan Bar-Chama, Director, Male Reproductive Medicine and Surgery, Associate Professor, Urology, Obstetrics, Gynecology and Reproductive Science, The Mount Sinai Hospital
-Dr. Nihal Mohamed, Assistant Professor, Urology, Icahn School of Medicine at Mount Sinai